These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4628582)

  • 41. High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
    Pommier Y; Pochat L; Marie JP; Zittoun RA
    Cancer Treat Rep; 1983 Apr; 67(4):371-3. PubMed ID: 6850654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
    Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
    Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
    [No Abstract]   [Full Text] [Related]  

  • 43. [High doses of cytosine arabinoside--a new use for an old drug].
    Klener P
    Cas Lek Cesk; 1984 Jul; 123(29):907. PubMed ID: 6488267
    [No Abstract]   [Full Text] [Related]  

  • 44. DNA synthesis during the life cycle of L cells: morphological, histochemical and biochemical investigations with arabinosylcytosine and thioarabinosylcytosine.
    Bremerskov V; Kaden P; Mittermayer C
    Eur J Cancer (1965); 1970 Oct; 6(5):379-92. PubMed ID: 5500706
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA
    Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680
    [No Abstract]   [Full Text] [Related]  

  • 47. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
    Inagaki A; Nakamura T; Wakisaka G
    Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487
    [No Abstract]   [Full Text] [Related]  

  • 48. Current and future aspects on the clinical use of Ara-C in leukemia. Proceedings from a symposium held at the 3rd European Conference on Clinical Oncology and Cancer Nursing, June 19, 1985, in Stockholm.
    Scand J Haematol Suppl; 1986; 44():1-74. PubMed ID: 3457436
    [No Abstract]   [Full Text] [Related]  

  • 49. Cellular pharmacodynamics of anticancer drugs.
    Plunkett W; Gandhi V
    Semin Oncol; 1993 Feb; 20(1):50-63. PubMed ID: 8475410
    [No Abstract]   [Full Text] [Related]  

  • 50. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
    Benckhuijsen C
    Folia Med Neerl; 1969 Dec; 12(2):74-84. PubMed ID: 4894168
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cytarabine: mechanism of action and clinical application].
    Eridani S
    Haematologica; 1972; 57(7):341-58. PubMed ID: 4628582
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.